These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 31990955)

  • 21. Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis.
    Guo Q; Jing FJ; Xu W; Li X; Li X; Sun JL; Xing XM; Zhou CK; Jing FB
    Aging (Albany NY); 2019 Dec; 12(1):80-105. PubMed ID: 31895687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
    Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
    Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docetaxel enhances the cytotoxicity of cisplatin to gastric cancer cells by modification of intracellular platinum metabolism.
    Maeda S; Sugiura T; Saikawa Y; Kubota T; Otani Y; Kumai K; Kitajima M
    Cancer Sci; 2004 Aug; 95(8):679-84. PubMed ID: 15298732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line.
    Viscarra T; Buchegger K; Jofre I; Riquelme I; Zanella L; Abanto M; Parker AC; Piccolo SR; Roa JC; Ili C; Brebi P
    Biol Res; 2019 Mar; 52(1):13. PubMed ID: 30894224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic alteration of gene expression induced by anticancer-agent exposure in gastric cancer cell lines.
    Takahashi T; Saikawa Y; Nakamura R; Kumagai K; Takeuchi H; Kubota T; Kitagawa Y
    Oncol Rep; 2009 Feb; 21(2):451-9. PubMed ID: 19148522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of exonuclease 1 caused by homology-dependent repair confers cisplatin resistance to gastric cancer cells.
    Mao P; Wu S; Fan Y
    Can J Physiol Pharmacol; 2022 Sep; 100(9):903-914. PubMed ID: 35767882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression.
    Zhu W; Tan L; Ma T; Yin Z; Gao J
    Dig Liver Dis; 2022 Nov; 54(11):1573-1582. PubMed ID: 35354542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro effect of a combination of 5-fluorouracil (5-FU) and cisplatin (CDDP) on human gastric cancer cell lines: timing of cisplatin treatment.
    Cho H; Imada T; Oshima T; Shiozawa M; Rino Y; Takanashi Y
    Gastric Cancer; 2002; 5(1):43-6. PubMed ID: 12021859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MFAP2 enhances cisplatin resistance in gastric cancer cells by regulating autophagy.
    Li M; Zhang HY; Zhang RG
    PeerJ; 2023; 11():e15441. PubMed ID: 37304872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2.
    Bao J; Xu Y; Wang Q; Zhang J; Li Z; Li D; Li J
    Biomed Pharmacother; 2017 Aug; 92():1030-1037. PubMed ID: 28609840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psoriasin overexpression confers drug resistance to cisplatin by activating ERK in gastric cancer.
    Li L; Cui Y; Ye L; Zhao Z; Jiang WG; Ji J
    Int J Oncol; 2018 Sep; 53(3):1171-1182. PubMed ID: 29956751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combining multi-dimensional data to identify a key signature (gene and miRNA) of cisplatin-resistant gastric cancer.
    Zhou D; Li X; Zhao H; Sun B; Liu A; Han X; Cui Z; Yuan L
    J Cell Biochem; 2018 Aug; 119(8):6997-7008. PubMed ID: 29693274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7.
    Zhou X; Jin W; Jia H; Yan J; Zhang G
    J Exp Clin Cancer Res; 2015 Mar; 34(1):28. PubMed ID: 25888377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.
    Hong WS; Jung HY; Yang SK; Kim HR; Min YI
    Anticancer Res; 1997; 17(5A):3613-6. PubMed ID: 9413212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer.
    Ikeguchi M; Kaibara N
    Int J Mol Med; 2001 Dec; 8(6):661-6. PubMed ID: 11712083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric Cancer Cell Lines Have Different
    Maués JHDS; Ribeiro HF; Pinto GR; Lopes LO; Lamarão LM; Pessoa CMF; Moreira-Nunes CFA; de Carvalho RM; Assumpção PP; Rey JA; Burbano RMR
    Can J Gastroenterol Hepatol; 2018; 2018():5804376. PubMed ID: 30410872
    [No Abstract]   [Full Text] [Related]  

  • 38. Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.
    Yu J; Li L; Huang C
    Med Sci Monit; 2017 Nov; 23():5542-5549. PubMed ID: 29161238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
    Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
    FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adipose most abundant 2 protein is a predictive marker for cisplatin sensitivity in cancers.
    Kamimura K; Suda T; Fukuhara Y; Okuda S; Watanabe Y; Yokoo T; Osaki A; Waguri N; Ishikawa T; Sato T; Aoyagi Y; Takamura M; Wakai T; Terai S
    Sci Rep; 2021 Mar; 11(1):6255. PubMed ID: 33737617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.